Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AGPAT5P1 (1-acylglycerol-3-phosphate O-acyltransferase 5 pseudogene 1) is a human pseudogene, meaning it is a genomic DNA sequence that closely resembles the functional AGPAT5 gene but has acquired mutations that prevent it from encoding a functional protein. Pseudogenes are categorized based on their origin and can sometimes be transcribed; while most are non-functional, some have emerging roles in gene regulation, such as acting as decoys for microRNAs or being involved in homologous recombination events affecting their parent gene. For AGPAT5P1, there is currently no evidence suggesting a regulatory or pathogenic role. It does not serve as a functional enzyme, receptor, or transporter, and is not recognized as a therapeutic target. In summary, AGPAT5P1 is a non-functional pseudogene without current relevance as a drug target, disease marker, or molecular mediator in human biology, except for its genome annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 1-acylglycerol-3-phosphate O-acyltransferase 5 pseudogene 1 (AGPAT5P1).